EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 20 / No 8-9 (Août-Septembre 2004) Med Sci (Paris), 20 8-9 (2004) 773-778 References
Free Access
Issue
Med Sci (Paris)
Volume 20, Number 8-9, Août-Septembre 2004
Page(s) 773 - 778
Section M/S revues
DOI https://doi.org/10.1051/medsci/2004208-9773
Published online 15 August 2004
  1. Brady AE, Limbird LE. G protein-coupled receptor interacting proteins : Emerging roles in localization and signal transduction. Cell Signal 2002; 14 : 297–309. [Google Scholar]
  2. Wimalawansa SJ. Calcitonin gene-related peptide and its receptors : Molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocrinol Rev 1996; 17 : 533–85. [Google Scholar]
  3. Dennis T, Fournier A, Cadieux A, et al. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 1990; 254 : 123–8. [Google Scholar]
  4. Quirion R, Van Rossum D, Dumont Y, et al. Characterization of CGRP1 and CGRP2 receptor subtypes. Ann NY Acad Sci 1992; 657 : 88–105. [Google Scholar]
  5. Chakravarty P, Suthar TP, Coppock HA, et al. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity-modifyng proteins (RAMPs) in rat tissues. Br J Pharmacol 2000; 130 : 189–95. [Google Scholar]
  6. Wimalawansa SJ. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin : A peptide superfamily. Crit Rev Neurobiol 1997; 11 : 167–239. [Google Scholar]
  7. Nandha KA, Taylor GM, Smith DM, et al. Specific adrenomedullin binding sites and hypotension in the rat systemic vascular bed. Regul Pept 1996; 62 : 145–51. [Google Scholar]
  8. McLatchie L, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin receptor like receptor. Nature 1998; 393 : 333–9. [Google Scholar]
  9. Evans BN, Rosenblatt MI, Mnayer LO, et al. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000; 275 : 31438–43. [Google Scholar]
  10. Luebke AE, Dahl GP, Roos BA, Dickerson IM. Identification of a protein that confers CGRP responsiveness to oocytes using CFTR assay. Proc Natl Acad Sci USA 1996; 93 : 3455–60. [Google Scholar]
  11. Prado MA, Evans-Bain B, Oliver KR, Dickerson IM. The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides 2001; 22 : 1773–81. [Google Scholar]
  12. Prado MA, Evans-Bain B, Dickerson IM. Receptor component protein (RCP) : A member of a multi-protein complex required for G-protein-coupled signal transduction. Biochem Soc Trans 2002; 30 : 460–4. [Google Scholar]
  13. Naghashpour M, Dahl G. Sensitivity of myometrium to CGRP varies during mouse estrous cycle and in response to progesterone. Am J Physiol Cell Physiol 2000; 278 : C561–9. [Google Scholar]
  14. Njuki F, Nicholl CG, Howard A, et al. A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci 1993; 85 : 385–8. [Google Scholar]
  15. Edvinsson L, Sams A, Jansen-Olesen I, et al. Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol 2001; 415 : 39–44. [Google Scholar]
  16. Chauhan M, Thota CS, Kondapaka S, et al. Evidence for the existence of a new receptor for CGRP, which is not CRLR. Peptides 2003; 24 : 65–71. [Google Scholar]
  17. Sexton PM, Albiston A, Morfis M, Tilakaratne N. Receptor activity modifying proteins. Cell Signal 2001; 13 : 73–83. [Google Scholar]
  18. Buhlmann N, Aldeoca A, Leuthauser K, et al. Glycosylation of the calcitonin receptor like receptor at Asn(60) or Asn(112) is important for cell surface expression. FEBS Lett 2000; 486 : 320–4. [Google Scholar]
  19. Flahaut M, Rossier BC, Firsov D. Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors. J Biol Chem 2002; 277 : 14731–7. [Google Scholar]
  20. Christopoulos G, Perry KJ, Morfis M, et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999; 56 : 235–42. [Google Scholar]
  21. Christopoulos A, Christopoulos G, Morfis M, et al. Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 2003; 278 : 3293–7. [Google Scholar]
  22. Poyner DR, Sexton PM, Marshall I, et al. International union of pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002; 54 : 233–46. [Google Scholar]
  23. Armour SL, Foord S, Kenakin T, Chen WJ. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. J Pharmacol Toxicol Meth 1999; 42 : 217–24. [Google Scholar]
  24. Muff R, Buhlmann N, Fisher JA, Born W. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying protein. Endocrinology 1999; 140 : 2924–27. [Google Scholar]
  25. Kuwasako K, Kitamura K, Nagoshi Y, Eto T. Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J Biol Chem 2003; 278 : 22623–30. [Google Scholar]
  26. Foord SM, Marshall FH. RAMPs : Accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 1999; 20 : 184–7. [Google Scholar]
  27. Aldecoa A, Gujer R, Fisher JA, Born W. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells. FEBS lett 2000; 471 : 156–60. [Google Scholar]
  28. Hilairet S, Foord SM, Marshall FH, Bouvier M. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J Biol Chem 2001; 276 : 29575–81. [Google Scholar]
  29. Gujer R, Aldecoa A, Buhlmann N, et al. Mutations of the asparagine 117 residue of a receptor activity-modifying protein 1 dependent human calcitonin gene-related peptide receptor result in selective loss of function. Biochemistry 2001; 40 : 5392–8. [Google Scholar]
  30. Kuwasako K, Kitamura K, Ito K, et al. The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors. J Biol Chem 2001; 276 : 49459–65. [Google Scholar]
  31. Tilakaratne N, Christopoulos G, Zumpe ET, et al. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J Pharmacol Exp Ther 2000; 294 : 61–72. [Google Scholar]
  32. Totsune KO, Takahashi K, Mackenzie HS, et al. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the heart of rats with congestive heart failure. Clin Sci 2000; 99 : 541–6. [Google Scholar]
  33. Oie E, Vinge LE, Yndestad A, et al. Induction of a myocardial adrenomedullin signalling system during ischemic heart failure in rats. Circulation 2000; 101 : 415–22. [Google Scholar]
  34. Cueille C, Pidoux E, De Vernejoul MC, Garel JM. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure. Biochem Biophys Res Commun 2002; 294 : 340–6. [Google Scholar]
  35. Nagae T, Mukoyama M, Sugawara A, et al. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor : Cloning and upregulation in obstructive nephropathy. Biochem Biophys Res Commun 2000; 270 : 89–93. [Google Scholar]
  36. Ono Y, Okano I, Kojima M, et al. Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. Biochem Biophys Res Commun 2000; 271 : 197–202. [Google Scholar]
  37. Qing X, Svaren J, Keith IM. mRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung. Am J Physiol Lung Cell Mol Physiol 2001; 280 : L547–54. [Google Scholar]
  38. Frayon S, Cueille C, Gnidéhou S, et al. Dexamethasone increases RAMP1 and CRLR mRNA expressions in human vascular smooth muscle cells. Biochem Biophys Res Commun 2000; 270 : 1063–7. [Google Scholar]
  39. Makino Y, Shibata K, Makino I, et al. Alteration of the adrenomedullin receptor component gene expression associated with the blood pressure in pregnancy-induced hypertension. J Clin Endocrinol Metab 2001; 86 : 5079–82. [Google Scholar]
  40. Nowak W, Parameswaran N, Hall CS, et al. Novel regulation of adrenomedullin receptor by PDGF : Role of receptor activity modifying. Am J Physiol Cell Physiol 2002; 282 : C1322–31. [Google Scholar]
  41. Roh J, Chang CL, Bhalla A, et al. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 2004; 279 : 7264–74. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.